2019-nCoV: Infectious virus can be isolated from nose, throat swabs of patients with mild symptoms

Laboratory testing by Charité - Universitätsmedizin Berlin, the Bundeswehr Institute of Microbiology and Munich Clinic Schwabing has revealed that infectious virus can be isolated from nose and throat swabs even where these have been obtained from patients with mild symptoms. The research groups have therefore come to the conclusion that even persons with mild symptoms are capable of transmitting the virus.

Charité's Institute of Virology and the Bundeswehr Institute of Microbiology have been supporting diagnostic efforts since the first case of 2019-nCoV infection was confirmed in Germany. Working independently of each other, both laboratories regularly monitor viral shedding in patients currently receiving treatment at Munich Clinic Schwabing. During the course of these investigations, the researchers found several cases in which infectious virus could be isolated from nose and throat swabs which had been obtained from patients with mild symptoms and propagated in cell culture. These patients presented with symptoms which were reminiscent of the common cold rather than severe pneumonia. Concomitant investigations by both laboratories also found evidence to suggest that the novel coronavirus replicates not only in the lungs but also in the nose, throat and gut.

Their combined observations indicate that even people with mild or early symptoms of common cold (sore throat, signs of sinusitis, mild malaise without fever) can pass on the virus. The investigations were led by Prof. Dr. Christian Drosten, Director of the Institute of Virology on Campus Charité Mitte, Colonel Priv.-Doz. Dr. Roman Wölfel of the Bundeswehr Institute of Microbiology and Prof. Clemens Wendtner, Head of the Department of Infectious Diseases and Tropical Medicine at Munich Clinic Schwabing.

It is important to Charité - Universitätsmedizin Berlin that the latest research findings on 2019-nCoV be made public without delay. The researchers' findings have been reported to the Robert Koch Institute and the Permanent Working Group of Medical Competence and Treatment Centers for High Consequence Infectious Diseases (STAKOB). Their data are being prepared for publication in a scientific journal.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Researchers discover a new monoclonal antibody that is effective against SARS-CoV-2 variants